N. Surmelioglu Et Al. , "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ," INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, pp.1-12, 2024
Surmelioglu, N. Et Al. 2024. Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. . INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496 , 1-12.
Surmelioglu, N., Demirturk, E., Ayhan, N. A., Yesilyurt, A. O., Bayrakci, S., Kaynak, M. S., ... Ozyilmaz, E.(2024). Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. . INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, 1-12.
Surmelioglu, NURSEL Et Al. "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ," INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, 1-12, 2024
Surmelioglu, NURSEL Et Al. "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ." INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, pp.1-12, 2024
Surmelioglu, N. Et Al. (2024) . "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ." INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, pp.1-12.
@article{article, author={NURSEL SÜRMELİOĞLU Et Al. }, title={Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. }, journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS}, year=2024, pages={1-12} }